Related Experiment Video
Updated: Aug 6, 2026
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Development of a New Tablet-Based Cognitive Screening Test for Community-Dwelling Older Adults
Masayuki Satoh1, Shin-Ichiro Maeshima2, Nao Hatakeyama3
1Neurology, Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Ōbu, JPN.
Cureus
|July 23, 2026
Summary
A new tablet-based tool, CANDIDE, shows promise for early cognitive decline screening in older adults. It correlates well with the MMSE-J, suggesting potential for accessible community health checks.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- Cognitive decline in community-dwelling older adults necessitates accessible, automated screening.
- Existing methods can burden healthcare personnel.
- A novel tablet-based tool was developed for integration into Specific Health Checkups (SHC).
Purpose of the Study:
- To develop and validate the "Cognitive Assessment for Community-Dwelling Older Adults" (CANDIDE) tool.
- To assess its feasibility for use by Minsei-iin (Commissioned Volunteer Community Welfare Officers).
- To determine the correlation between CANDIDE and the Mini-Mental State Examination Japanese version (MMSE-J).
Main Methods:
- Developed CANDIDE, an 8-minute tablet-based cognitive test.
- Administered CANDIDE and MMSE-J to 70 hospital outpatients over six months.
- Used auditory and visual instructions for diverse sensory needs.
- Analyzed statistical correlation to establish a provisional cutoff score.
Main Results:
- 70 participants (mean age 80.9 years) completed the study.
- Strong positive correlation found between CANDIDE and MMSE-J scores (r = 0.721, p < 0.001).
- A MMSE-J cutoff score of 24 corresponded to a CANDIDE score of 21.2.
Conclusions:
- CANDIDE appears feasible for screening cognitive decline in individuals aged 40-74.
- Further research is needed to validate its clinical utility and cost-effectiveness within the SHC framework.
- Efficacy as an objective assessment tool for Minsei-iin requires additional investigation.
